Načítá se...
Randomized Controlled Trial of Rituximab in Patients With Graves' Orbitopathy
CONTEXT: Graves' orbitopathy (GO) is a potentially sight-threatening disease for which available medical therapy is not uniformly successful. Multiple case series suggest that rituximab (RTX) may be effective therapy for GO patients. OBJECTIVE: To determine the efficacy of RTX in GO. DESIGN: It...
Uloženo v:
| Vydáno v: | J Clin Endocrinol Metab |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Endocrine Society
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4318907/ https://ncbi.nlm.nih.gov/pubmed/25343233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-2572 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|